137 related articles for article (PubMed ID: 13813934)
1. Maple syrup urine disease: branched-chain keto-aciduria.
DANCIS J; LEVITZ M; WESTALL RG
Pediatrics; 1960 Jan; 25():72-9. PubMed ID: 13813934
[No Abstract] [Full Text] [Related]
2. Neuropathological observations in maple syrup urine disease: branched-chain ketoaciduria.
SILBERMAN J; DANCIS J; FEIGIN I
Arch Neurol; 1961 Oct; 5():351-63. PubMed ID: 13912814
[No Abstract] [Full Text] [Related]
3. Clinical and biochemical observations on an apparently nonfatal variant of branched-chain ketoaciduria (maple syrup urine disease).
MORRIS MD; LEWIS BD; DOOLAN PD; HARPER HA
Pediatrics; 1961 Dec; 28():918-23. PubMed ID: 14476272
[No Abstract] [Full Text] [Related]
4. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
[No Abstract] [Full Text] [Related]
5. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
[No Abstract] [Full Text] [Related]
6. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
[TBL] [Abstract][Full Text] [Related]
7. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
8. A variant form of branched-chain keto aciduria.
van der Horst JL; Wadman SK
Acta Paediatr Scand; 1971 Sep; 60(5):594-9. PubMed ID: 5125167
[No Abstract] [Full Text] [Related]
9. Gas-liquid chromatography of alpha-keto acids: quantification of the branched-chain-alpha-keto acids from physiological sources.
Cree TC; Hutson SM; Harper AE
Anal Biochem; 1979 Jan; 92(1):159-63. PubMed ID: 426274
[No Abstract] [Full Text] [Related]
10. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
[TBL] [Abstract][Full Text] [Related]
11. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
SILBERMANSCHWARTZMAN J
An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
[No Abstract] [Full Text] [Related]
12. Late-onset branched-chain ketoaciduria: (maple syrup urine disease).
Morris MD; Fisher DA; Fiser R
J Lancet; 1966 Mar; 86(3):149-52. PubMed ID: 5904649
[No Abstract] [Full Text] [Related]
13. The gas-chromatographic diagnosis of intermittent maple syrup urine disease (branch-chain ketoaciduria).
Gompertz D; Draffan GH
Clin Chim Acta; 1972 Aug; 40(1):5-11. PubMed ID: 5056643
[No Abstract] [Full Text] [Related]
14. Branched-chain alpha-keto acids isolated as oxime derivatives: relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease.
Lancaster G; Mamer OA; Scriver CR
Metabolism; 1974 Mar; 23(3):257-65. PubMed ID: 4813956
[No Abstract] [Full Text] [Related]
15. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
[No Abstract] [Full Text] [Related]
16. Family with intermittent maple syrup urine disease.
Valman HB; Patrick AD; Seakins JW; Platt JW; Gompertz D
Arch Dis Child; 1973 Mar; 48(3):225-8. PubMed ID: 4693464
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
Snyderman SE; Goldstein F; Sansaricq C; Norton PM
Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease in calves: a clinical, pathological and biochemical study.
Harper PA; Dennis JA; Healy PJ; Brown GK
Aust Vet J; 1989 Feb; 66(2):46-9. PubMed ID: 2712767
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of branched-chain alpha-keto acids as their trimethylsilylated oximes.
Lancaster G; Lamm P; Scriver CR; Tjoa SS; Mamer OA
Clin Chim Acta; 1973 Oct; 48(3):279-85. PubMed ID: 4765708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
